Navigation Links
Pharmacopeia to Present at The Roth 20th Annual OC Growth Stock Conference
Date:2/13/2008

PRINCETON, N.J., Feb. 13 /PRNewswire-FirstCall/ -- Pharmacopeia (Nasdaq: PCOP), an innovator in the discovery and development of novel small molecule therapeutics, today announced that Dr. Leslie J. Browne, President and Chief Executive Officer, will deliver a corporate presentation at the Roth 20th Annual OC Growth Stock Conference. The conference will be held February 18-21, 2008, at The Ritz Carlton Laguna Niguel in Dana Point, CA.

Dr. Browne's presentation will take place at 10:30 a.m. local time on Thursday, February 21st. The presentation will include an overview of the company's drug development pipeline, including an update on its internal clinical programs, PS433540 (DARA), which is progressing in Phase 2, and PS178990 (SARM), which is currently in Phase 1. A live webcast and 90-day archive of the presentation can be accessed at http://www.pharmacopeia.com.

ABOUT PHARMACOPEIA

Pharmacopeia is a clinical development stage biopharmaceutical company dedicated to discovering and developing novel small molecule therapeutics to address significant medical needs. The company has a broad portfolio of clinical and preclinical candidates under development internally or by partners including seven clinical compounds in Phase 2 or Phase 1 development addressing multiple indications including hypertension, diabetic nephropathy, muscle wasting, inflammation and respiratory disease. The company is leveraging its fully integrated drug discovery platform to sustain the growth of its development pipeline. Pharmacopeia has established strategic agreements with major pharmaceutical and biotechnology companies, including Bristol-Myers Squibb, Celgene, Cephalon, GlaxoSmithKlin
'/>"/>

SOURCE Pharmacopeia
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. USP publishes Spanish edition of United States Pharmacopeia and National Formulary
2. USP Publishes Spanish Edition of United States Pharmacopeia and National Formulary
3. U.S. Pharmacopeia 8th Annual MEDMARX(R) Report Indicates Look-Alike/Sound-Alike Drugs Lead to Thousands of Medication Errors Nationwide
4. US Pharmacopeia partners with Quantros to enhance the MEDMARX patient safety reporting program
5. Pharmacopeia and GlaxoSmithKline Collaboration Identifies Two Additional Lead Compounds
6. Pharmacopeia Acquires Selective Androgen Receptor Modulator (SARM) Program from Bristol-Myers Squibb
7. Pharmacopeia Announces Senior Additions to Management Team
8. Pet DRx to Present at Roth 20th Annual OC Growth Stock Conference
9. AtriCure to Present at Roth Capital Partners 20th Annual OC Conference
10. Gen-Probe to Webcast Presentation at Deutsche Bank Small- and Mid-Cap Growth Conference
11. Inexpensive Online Pain Education Program for Physicians as Effective as Live Presentations by National Experts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... ... August 04, 2015 , ... ... examination now offered by the world renowned Beverly Hills facelift surgeon , ... through cosmetic surgery techniques helps individuals to achieve an outer appearance that meets ...
(Date:8/4/2015)... Denver, CO (PRWEB) , ... August 04, 2015 ... ... for skilled nursing homes and other long-term care facilities, today announced details of ... (QAPI) for nursing homes and centers. , Providigm’s QAPI Accreditation program , ...
(Date:8/4/2015)... (PRWEB) , ... August 04, ... ... its HealthCenter personal health record (PHR) product has achieved Office of the ... Inpatient EHR Certification from Drummond Group. HealthCenter delivers the highest quality personal ...
(Date:8/4/2015)... ... ... METTLER TOLEDO has announced an upcoming online symposium entitled ... and Merck. This free online seminar will be held on September 24, ... decisions with limited process understanding. Established methods have been developed to facilitate ...
(Date:8/4/2015)... ... ... The results of a three year clinical trial for the Argus II, a ... blindness, were published on June 23, 2015 in Ophthalmology , the journal of ... more commonly known as the “bionic eye,” is safe and effective for long-term treatment ...
Breaking Medicine News(10 mins):Health News:Beverly Hills Surgeon, Dr. Paul Nassif, is Now Offering Personal Consultations with Full Examinations for Facial Plastic Surgeries 2Health News:Beverly Hills Surgeon, Dr. Paul Nassif, is Now Offering Personal Consultations with Full Examinations for Facial Plastic Surgeries 3Health News:Nursing Homes Achieving New Advanced Accreditation See Improved Measures of Quality, Better Occupancy Rates 2Health News:Nursing Homes Achieving New Advanced Accreditation See Improved Measures of Quality, Better Occupancy Rates 3Health News:MedicaSoft's HealthCenter Earns ONC-HIT Certification from Drummond Group 2Health News:MedicaSoft's HealthCenter Earns ONC-HIT Certification from Drummond Group 3Health News:METTLER TOLEDO Announces New Process Chemistry and Scale-up Online Seminar 2Health News:“Bionic Eye” Implant for the Blind Proved Safe and Effective at the End of a Three Year Clinical Trial 2
... National Government Services subsidiary Medicare ... York and Connecticut, INDIANAPOLIS, May 5 WellPoint, ... Inc.,subsidiary was selected by the Centers for Medicare & ... Jurisdiction 13,which includes the states of New York and ...
... kidney disease from high blood pressure did not keep ... of African-Americans studied, according to long-term results of a ... in the Archives of Internal Medicine. , The largest ... the African American Study of Kidney Disease and ...
... more with exclusive summer ... travel packages for 2008., SAN RAFAEL, ... Hotels & Restaurants Group announced today a,series of travel packages for ... KN Tranquility Suite(TM) offers opulent, comfort-inspired,surroundings in the heart of Chicago,s ...
... 5 ConforMIS, Inc., a privately,held company that ... treatment of osteoarthritis and joint damage, today,announced the ... Officer.,The addition fully rounds out the executive team, ... Chief Executive Officer and Phil Licari,as Chief Operating ...
... fewer brain bleeds than aspirin, study finds , , MONDAY, May ... good as aspirin at preventing recurrent stroke and it causes ... Peking University First Hospital in Beijing shows. , The trial ... to 18 months and 359 patients who took aspirin for ...
... prescriptions for $10, more women,s health offerings, and $4 ... BENTONVILLE, Ark., May 5 While health care,costs ... Stores, Inc.,(NYSE: WMT ) is furthering its efforts ... costs and providing ongoing savings,through its pharmacy offerings., ...
Cached Medicine News:Health News:WellPoint Wins Medicare Administrative Contract Worth up to $323 Million 2Health News:Kidney disease worsens in a fourth of African-Americans despite therapy for hypertension 2Health News:KN Tranquility Suite(TM) Hosts Spa Indulgences and High-Tea Service on the Magnificent Mile 2Health News:KN Tranquility Suite(TM) Hosts Spa Indulgences and High-Tea Service on the Magnificent Mile 3Health News:ConforMIS Completes Executive Team With Addition of CFO 2Health News:Anti-Clotting Drug as Good as Aspirin at Stopping Second Stroke 2Health News:Wal-Mart Launches Phase Three of $4 Prescription Program 2Health News:Wal-Mart Launches Phase Three of $4 Prescription Program 3Health News:Wal-Mart Launches Phase Three of $4 Prescription Program 4
(Date:8/4/2015)... 2015  Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ) ... million for the three and six months ended June ... $12.1 million and $43.4 million for the same periods ... primarily by the more than $90 million of revenue ... upfront payment from Bayer to license  ISIS-FXI Rx .  ...
(Date:8/4/2015)... Aug. 4, 2015  Armada Health Care ... Medical School,s Clinical Pharmacy Services business unit ... protocols and therapy interventions within the ArmadaOne ... Specialty medication therapy management is an essential ... optimal patient outcomes are achieved through timely ...
(Date:8/4/2015)... 2015  Delcath Systems, Inc. (NASDAQ: DCTH ), ... oncology with an emphasis on the treatment of primary ... data from studies in Europe ... CHEMOSAT ® Delivery System (CHEMOSAT) will be presented at ... which will be held in Marseille, France ...
Breaking Medicine Technology:Isis Reports Financial Results And Highlights For Second Quarter 2015 2Isis Reports Financial Results And Highlights For Second Quarter 2015 3Isis Reports Financial Results And Highlights For Second Quarter 2015 4Isis Reports Financial Results And Highlights For Second Quarter 2015 5Isis Reports Financial Results And Highlights For Second Quarter 2015 6Isis Reports Financial Results And Highlights For Second Quarter 2015 7Isis Reports Financial Results And Highlights For Second Quarter 2015 8Isis Reports Financial Results And Highlights For Second Quarter 2015 9Isis Reports Financial Results And Highlights For Second Quarter 2015 10Isis Reports Financial Results And Highlights For Second Quarter 2015 11Isis Reports Financial Results And Highlights For Second Quarter 2015 12Isis Reports Financial Results And Highlights For Second Quarter 2015 13Isis Reports Financial Results And Highlights For Second Quarter 2015 14Isis Reports Financial Results And Highlights For Second Quarter 2015 15Isis Reports Financial Results And Highlights For Second Quarter 2015 16Armada Health Care collaborates with University of Massachusetts Medical School for ArmadaOne Specialty Pharmacy Platform 2Armada Health Care collaborates with University of Massachusetts Medical School for ArmadaOne Specialty Pharmacy Platform 3Delcath Announces Acceptance of Abstracts for Presentation at the European Association of Dermato Oncology Annual Congress 2Delcath Announces Acceptance of Abstracts for Presentation at the European Association of Dermato Oncology Annual Congress 3Delcath Announces Acceptance of Abstracts for Presentation at the European Association of Dermato Oncology Annual Congress 4
... YORK and KANSAS CITY, Mo., Sept. 19, 2011 ... lower carbon dioxide emissions, Duane Reade today announced a ... all-electric commercial trucks to its delivery fleet. With the ... first retail pharmacy in the United States to choose ...
... 2011 Delcath Systems, Inc. (NASDAQ: DCTH ) ... Healthcare Conference on Wednesday, September 28, 2011 at 11:00 A.M. ... will provide an overview of the Company,s business strategy and ... is by invitation only.  Delcath will offer a live webcast ...
Cached Medicine Technology:Duane Reade and Smith Electric Vehicles Partner to Bring All-Electric Delivery Vehicles to New York's Streets 2Duane Reade and Smith Electric Vehicles Partner to Bring All-Electric Delivery Vehicles to New York's Streets 3Delcath to Present at the JMP Securities Healthcare Conference on September 28, 2011 2Delcath to Present at the JMP Securities Healthcare Conference on September 28, 2011 3
... device for the qualitative detection of drug or ... device can detect up to nine of the ... minutes and requires only a few drops of ... maximize convenience and ease of use. TOX/See features ...
... hand-held, point-of-care device for the qualitative detection of ... The TOX/See device can detect up to nine ... to 8 minutes and requires only a few ... packaged to maximize convenience and ease of use. ...
... device for the qualitative detection of drug or ... device can detect up to nine of the ... minutes and requires only a few drops of ... maximize convenience and ease of use. TOX/See features ...
... is a 1-step, hand-held, point-of-care device for the ... human urine. The TOX/See device can detect ... drugs in 3 to 8 minutes and requires ... cassette is individually packaged to maximize convenience and ...
Medicine Products: